The antiproliferative effect of mizoribine on rheumatoid synovial fibroblast mediated by induction of apoptosis

Kobe Journal of Medical Sciences

Volumn 47, Issue 1, 2001, Pages 13-23

  Imaizumi, Y ^a   Saura, R ^a   Mizuno, K ^a   Nakagami, K ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Bcl 2; Mizoribine; Rheumatoid arthritis; Synovial fibroblast

Indexed keywords

DNA FRAGMENT; MIZORIBINE; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; PANNUS; PROTEIN EXPRESSION; PROTO ONCOGENE; RHEUMATOID ARTHRITIS; SYNOVIOCYTE;

APOPTOSIS; ARTHRITIS, RHEUMATOID; CELL DIVISION; CELLS, CULTURED; DNA; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PROTO-ONCOGENE PROTEINS C-BCL-2; RIBONUCLEOSIDES; SYNOVIAL MEMBRANE;

EID: 0034834291     PISSN: 00232513     EISSN: 18830498     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. In situ expression of protooncogenes and Fas/Fas ligand in rheumatoid arthritis synovium
2. Clinical laboratory outcomes during the treatment of rheumatoid arthritis with methotrexate
3. GTP depletion induced by IMP dehydrogenase inhibitors blocks RNA-primed DNA synthesis
4. Apoptosis in rheumatoid arthritis synovium
5. Pathogenesis of rheumatoid arthritis
6. Early aggressive DMARD therapy: The key to slowing disease progression in rheumatoid arthritis
7. Mizoribine and mycophenolate mofetil
8. Effect of mizoribine on effector T cell-mediated immune responses in mice
9. Immunosuppression by OKT3-induction of programmed cell death (apoptosis) as a possible mechanism of action
10. A new triple-drug induction therapy with low dose cyclosporine, mizoribine and prednisolone in renal transplantation
11. Regulators of cell death
12. A case of recurrent lupus nephritis after renal transplantation
13. Drug treatment for rheumatoid arthritis
14. Prolonged depletion of guanosine triphosphate induces death of insulin-secreting cells by apoptosis
15. Ultrastructural demonstration of apoptosis, Fas and Bcl-2 expression of rheumatoid synovial fibroblasts
16. Regulation of rheumatoid synovial cell growth by ceramide
17. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes
18. Apoptosis in rheumatoid arthritis: A novel pathway in the regulation of synovial tissue
19. Cell-mediated immunity in rheumatic disease
20. Bcl-2 family proteins: Regulators of apoptosis and chemoresistance in hematologic malignancies
21. Induction of cytokines and ICAM-1 by proinflammatory cytokines in primary rheumatoid synovial fibroblasts and inhibition by N-acetyl-L-cysteine and aspirin
22. Inhibition of human endothelial cell and RA synovial fibroblast proliferation by a novel anti-rheumatic drug, mizoribine
23. Fas antigen expression on synovial cells was down-regulated by interleukin 1 β
24. Guanine ribonucleotide depletion inhibits T cell activation. Mechanism of action of the immunosuppressive drug mizoribine
25. Effectiveness of a new drug, bredinin, on canine kidney allotransplant survival
26. Modulation by proinflammatory cytokines of Fas/Fas ligand-mediated apoptotic cell death of synovial cells in patients with rheumatoid arthritis (RA)
27. Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells
28. The immunopathology of joint inflammation in rheumatoid arthritis